Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Bossi

Showing results (11-20 of 383) with videos related to

Pageof 39
Sort By:
Frontiers in Oncology|January 24, 2022
Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and PerspectivesAndrea Alberti, Paolo Bossi
Current Opinion in Oncology|March 12, 2025
New trends in supportive care of head and neck cancersIlaria Mascagni, Paolo Bossi
Oral Oncology|December 21, 2022
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Hypothesis coming from the subgroup analysisFrancesca De Felice, Paolo Bossi
Frontiers in Oncology|January 3, 2022
Editorial: Advances in the Multidisciplinary Management of Oral CancerAlberto Paderno, Paolo Bossi, Cesare Piazza
Advances in Oto-Rhino-Laryngology|July 31, 2020
The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal CancerLisa Licitra, Carlo Resteghini, Paolo Bossi
Current Opinion in Supportive and Palliative Care|April 15, 2015
Gastrointestinal toxicities from targeted therapies: measurement, duration and impactPaolo Bossi, Maurizio Lucchesi, Andrea Antonuzzo
Oral Oncology|August 16, 2025
PD-L1 Expression in head and neck squamous cell carcinoma: qualitative or quantitative assessment? Is that enough or we need something more?Riccardo Gili, Patrizia Morbini, Paolo Bossi
The Lancet. Oncology|July 1, 2021
Patient selection for immunotherapy in head and neck cancerPierluigi Bonomo, Ester Orlandi, Paolo Bossi
Frontiers in Pain Research (Lausanne, Switzerland)|June 20, 2022
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily PracticePaolo Bossi, Yolanda Escobar, Federico Pea
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2021
Peripherally or centrally inserted central catheters: what is the best vascular access device for cancer patients?Silvia Gonella, Andrea Antonuzzo, Paolo Bossi
Pageof 39

Showing results (11-20 of 383) with videos related to

Sort By:
Pageof 39
Frontiers in Oncology|January 24, 2022
Immunotherapy for Cutaneous Squamous Cell Carcinoma: Results and PerspectivesAndrea Alberti, Paolo Bossi
Current Opinion in Oncology|March 12, 2025
New trends in supportive care of head and neck cancersIlaria Mascagni, Paolo Bossi
Oral Oncology|December 21, 2022
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Hypothesis coming from the subgroup analysisFrancesca De Felice, Paolo Bossi
Frontiers in Oncology|January 3, 2022
Editorial: Advances in the Multidisciplinary Management of Oral CancerAlberto Paderno, Paolo Bossi, Cesare Piazza
Advances in Oto-Rhino-Laryngology|July 31, 2020
The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal CancerLisa Licitra, Carlo Resteghini, Paolo Bossi
Current Opinion in Supportive and Palliative Care|April 15, 2015
Gastrointestinal toxicities from targeted therapies: measurement, duration and impactPaolo Bossi, Maurizio Lucchesi, Andrea Antonuzzo
Oral Oncology|August 16, 2025
PD-L1 Expression in head and neck squamous cell carcinoma: qualitative or quantitative assessment? Is that enough or we need something more?Riccardo Gili, Patrizia Morbini, Paolo Bossi
The Lancet. Oncology|July 1, 2021
Patient selection for immunotherapy in head and neck cancerPierluigi Bonomo, Ester Orlandi, Paolo Bossi
Frontiers in Pain Research (Lausanne, Switzerland)|June 20, 2022
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily PracticePaolo Bossi, Yolanda Escobar, Federico Pea
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 30, 2021
Peripherally or centrally inserted central catheters: what is the best vascular access device for cancer patients?Silvia Gonella, Andrea Antonuzzo, Paolo Bossi
Pageof 39